Thursday, March 4, 2010


The Centers For Disease Control(CDC) and other government "health" agencies have not had a very good track record when it comes to real prevention and cures for disease. Prevention and Cures do not turn a profit. Keeping people sick through avoidance of real research, misappropriations of funds, and promoting only symptomatic treatments instead of treating the root causes, feeds the healthcare monopoly and results in chronic disease and pharmacological control of the people. Government agencies have become intimately intertwined with corporations. I believe that this state of affairs is termed Fascism.

If we expect the government to take control of our feed us, to protect us, to heal us and educate us...then essentially they are playing the role of a parent but without the concern and love of a parent. Government/Corporations are an entity, without conscience or compassion. In the past I have written about chronic illnesses and how Charities (which are supposedly nonprofit) and government "health" agencies have created many separate disease labels for conditions that are often caused by microbes and unhealthy immune systems. Our unhealthy immune systems are largely due to modern food commerce and false nutritional information given out by the very same entities which are there to profit from the unhealthy results of diet disinformation.

When conducting studies, instead of researching routes of disease transmission, effect of diet on immune function... or pleomorphism , for example, studies are conducted which will only result in symptomatic treatments (to cover up the symptoms and ignore the cause). As I mentioned and control is often the real motivation here. Once most of the population is sick and dependant on the drugs can imagine the rest.

My intention here is not to bash the CDC or to imply that this Lyme disease study was organized with nefarious goals in mind. However, I do believe there needs to be more public oversight and input into how these studies are conducted and examination into the actual premise of the studies.Concerning the study below, it can sound hopeful to many of us...but what is their premise? It looks as though they are assuming that adequate treatment is the IDSA defined guidelines (3 to 4 weeks of antibiotics). Those who are living in the world of Chronic Lyme disease, realize that this point...there should not be any restrictive absolute length of treatment. All patients are different, with different coinfections and length of time the disease has gone untreated. Different strains of the Lyme bacteria may require different antibiotics and different treatment lengths. There are over 300 strains of the Lyme causing bacteria. Only a couple of strains are being tested for. what criteria is being used to be able to say with such certainty that Lyme disease is always cured within the "official" treatment length? In addition to the many strains which are not being tested for, the testing for the one or two strains they chose to create tests extremely inaccurate. Again.....what definite criteria is being used to determine whether or not the Lyme spirochetes are totally eliminated?

I am not an organizer or a legislative activist but I am sharing my thoughts here so that hopefully those who are more inclined in this area will think more on this angle of  demanding public oversight....or only funding private researchers whom we trust. We can hand over millions of dollars to the CDC to study Lyme disease but we must look at their past record with Lyme disease and Chronic Fatigue Syndrome and the misappropriations which have occurred. The way studies are set very important. We need to think through to the probable conclusions of these studies.

Below is a brief description of the study from the website given below. The description indentifies Chronic Lyme disease as "post-treatment Lyme disease syndrome". What are the implications of that disease label?


The Centers for Disease Control and Prevention (CDC) announces the availability of Fiscal Year (FY) 2010 funds for a grant for research on post-treatment Lyme disease syndrome (PLDS). The purpose of the program is to gain insight into epidemiological and clinical features of post-treatment Lyme disease syndrome that may be used to guide the development of future treatment and prevention efforts.


No comments:

Post a Comment